Xtl Biopharmaceuticals (XTLB) Change in Acquisitions & Divestments (2009 - 2014)
Xtl Biopharmaceuticals (XTLB) posted quarterly Change in Acquisitions & Divestments of $4000.0 for Q2 2014, down 98.63% on a QoQ basis from $291000.0 in Q1 2014.
Xtl Biopharmaceuticals (XTLB) Change in Acquisitions & Divestments (2009 - 2014) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Change in Acquisitions & Divestments for 6 consecutive years, with $4000.0 the latest figure, recorded in Q2 2014.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $4000.0 in Q2 2014, while the trailing twelve-month figure through Dec 2014 was $295000.0 (down 90.25% YoY) and the FY2025 annual result came in at $777000.0, changed N/A from the prior year.
- Change in Acquisitions & Divestments eased to $4000.0 in Q2 2014 per XTLB's latest filing, from $291000.0 in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for XTLB reached as high as $2.7 million in Q3 2013 and fell as low as -$44000.0 in Q3 2010.
- A 5-year average of $269250.0 and a median of -$4000.0 in 2010 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2011 — Change in Acquisitions & Divestments grew 16.67% — and 2013, when it surged 8354.55%.
- Year by year, Change in Acquisitions & Divestments stood at -$6000.0 in 2010, then climbed by 16.67% to -$5000.0 in 2011, then jumped by 180.0% to $4000.0 in 2012, then surged by 8150.0% to $330000.0 in 2013, then sank by 98.79% to $4000.0 in 2014.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $4000.0, $291000.0, and $330000.0 for Q2 2014, Q1 2014, and Q4 2013 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 4,000.00 |
| Jun 30, 2014 | 4,000.00 |
| Mar 31, 2014 | 291,000.00 |
| Mar 31, 2014 | 291,000.00 |
| Dec 31, 2013 | 330,000.00 |
| Dec 31, 2013 | 330,000.00 |
| Sep 30, 2013 | 2.72 Mn |
| Sep 30, 2013 | 2.72 Mn |
| Dec 31, 2012 | 4,000.00 |
| Dec 31, 2012 | 4,000.00 |
| Sep 30, 2012 | -33,000.00 |
| Sep 30, 2012 | -33,000.00 |
| Dec 31, 2011 | -5,000.00 |
| Dec 31, 2011 | -5,000.00 |
| Mar 31, 2011 | -3,000.00 |
| Mar 31, 2011 | -3,000.00 |
| Dec 31, 2010 | -6,000.00 |
| Dec 31, 2010 | -6,000.00 |
| Sep 30, 2010 | -44,000.00 |
| Sep 30, 2010 | -44,000.00 |